Cosmos Health (NASDAQ:COSM) CEO Grigorios Siokas Acquires 388,532 Shares

Cosmos Health Inc. (NASDAQ:COSM) CEO Grigorios Siokas purchased 388,532 shares of the firm’s stock in a transaction that occurred on Thursday, February 12th. The shares were acquired at an average cost of $0.37 per share, with a total value of $143,756.84. Following the completion of the transaction, the chief executive officer directly owned 8,861,914 shares of the company’s stock, valued at $3,278,908.18. The trade was a 4.59% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Grigorios Siokas also recently made the following trade(s):

• On Wednesday, February 11th, Grigorios Siokas acquired 291,262 shares of Cosmos Health stock. The shares were acquired at an average cost of $0.41 per share, for a total transaction of $119,417.42.
• On Friday, January 23rd, Grigorios Siokas bought 90,325 shares of Cosmos Health stock. The shares were acquired at an average price of $0.50 per share, with a total value of $45,162.50.
• On Tuesday, January 20th, Grigorios Siokas bought 353,321 shares of Cosmos Health stock. The stock was purchased at an average price of $0.50 per share, with a total value of $176,660.50.
• On Wednesday, January 14th, Grigorios Siokas bought 493,495 shares of Cosmos Health stock. The shares were purchased at an average cost of $0.45 per share, for a total transaction of $222,072.75.
• On Monday, January 12th, Grigorios Siokas bought 113,185 shares of Cosmos Health stock. The shares were bought at an average price of $0.50 per share, for a total transaction of $56,592.50.
• On Thursday, January 8th, Grigorios Siokas bought 156,190 shares of Cosmos Health stock. The shares were acquired at an average cost of $0.52 per share, with a total value of $81,218.80.
• On Wednesday, January 7th, Grigorios Siokas purchased 124,880 shares of Cosmos Health stock. The stock was acquired at an average cost of $0.52 per share, with a total value of $64,937.60.
• On Tuesday, January 6th, Grigorios Siokas purchased 133,953 shares of Cosmos Health stock. The shares were acquired at an average price of $0.54 per share, with a total value of $72,334.62.
• On Friday, December 19th, Grigorios Siokas acquired 88,314 shares of Cosmos Health stock. The stock was acquired at an average price of $0.49 per share, for a total transaction of $43,273.86.
• On Monday, December 15th, Grigorios Siokas purchased 168,472 shares of Cosmos Health stock. The stock was bought at an average cost of $0.42 per share, with a total value of $70,758.24.

Cosmos Health Stock Up 3.7%

Cosmos Health stock traded up $0.01 during midday trading on Friday, reaching $0.39. The stock had a trading volume of 371,548 shares, compared to its average volume of 1,128,203. The company has a market capitalization of $14.49 million, a P/E ratio of -0.52 and a beta of 5.36. The company has a current ratio of 0.99, a quick ratio of 0.84 and a debt-to-equity ratio of 0.25. Cosmos Health Inc. has a 12 month low of $0.28 and a 12 month high of $1.32. The company has a fifty day moving average price of $0.49 and a two-hundred day moving average price of $0.73.

Cosmos Health (NASDAQ:COSM) last posted its quarterly earnings data on Friday, November 14th. The company reported ($0.17) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.16). The company had revenue of $17.11 million for the quarter, compared to analysts’ expectations of $16.40 million. Cosmos Health had a negative return on equity of 33.19% and a negative net margin of 31.01%. As a group, equities analysts expect that Cosmos Health Inc. will post -0.78 EPS for the current fiscal year.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Cosmos Health in a report on Wednesday, January 21st. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company presently has an average rating of “Sell”.

Hedge Funds Weigh In On Cosmos Health

A hedge fund recently raised its stake in Cosmos Health stock. Renaissance Technologies LLC increased its holdings in Cosmos Health Inc. (NASDAQ:COSM) by 260.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 334,575 shares of the company’s stock after purchasing an additional 241,775 shares during the quarter. Renaissance Technologies LLC owned 0.89% of Cosmos Health worth $167,000 as of its most recent filing with the Securities & Exchange Commission. Institutional investors own 12.61% of the company’s stock.

About Cosmos Health

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.